|
|
 |
|
Viewing report
|
|
|
|
Baxter International Medical Device Company Intelligence Report
Espicom Business Intelligence Ltd, March 2009, Pages: 44
Baxter International Inc develops, manufactures and markets products with the purpose of saving and sustaining the lives of people with haemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company applies a combination of expertise in medical devices, pharmaceuticals and biotechnology and operates in three segments:
Medication Delivery – manufactures intravenous (IV) solutions and administration sets, pre-mixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps and inhalation anaesthetics, as well as products and services related to pharmacy compounding, drug formulation and packaging technologies.
Renal – provides products to treat end-stage renal disease, or irreversible kidney failure. The business manufactures solutions and other products for peritoneal dialysis (PD), a home-based therapy, and also distributes products for haemodialysis (HD), which is generally conducted in a hospital or clinic.
BioScience – manufactures recombinant and plasma-based proteins to treat haemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines.
Prior to the divestiture of the Transfusion Therapies (TT) business in February 2007, the BioScience segment also manufactured manual and automated blood and blood-component separation and collection systems.
This profile mainly concentrates on Baxter’s medical device activities.
Baxter has approximately 48,500 employees and conducts business in over 100 countries. The company generates approximately 60% of its revenues outside of the US, and maintains manufacturing and distribution facilities in a number of locations in the US, Europe, Canada, Asia, Latin America and Australia.
Customers who bought this item also bought
Blood Banking & Blood Products - Global Strategic Business Report
Baxter International Inc. Medical Equipment Company Share Analysis
Baxter International Inc.
Baxter International Inc. - Financial and Strategic Analysis Review
Renal Anemia: Early Diagnosis and Management of Anemia: Reducing Costs and Improving the Outcomes in Chronic Kidney Disease
Baxter International Inc. - SWOT Analysis
Blood and Lymphatic System - Hemophilia or Blood Coagulation Disorders Drug Pipeline Report
Blood Banking and Blood Products - Global Market Perspective
Blood Banking and Blood Products - Global Market Perspective
Baxter International Inc. - Healthcare - Medical Equipment SWOT Report
Kidney Dialysis Equipment and Supplies - Global Strategic Business Report
Pricing and Reimbursement Issues for Immune Disease Therapies
|
|
|
|
